These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11053961)

  • 1. Long-term remission of idiopathic cervical dystonia after treatment with botulinum toxin.
    Giladi N; Meer J; Kidan H; Honigman S
    Eur Neurol; 2000; 44(3):144-6. PubMed ID: 11053961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A.
    Brashear A; Bergan K; Wojcieszek J; Siemers ER; Ambrosius W
    Mov Disord; 2000 Jan; 15(1):150-3. PubMed ID: 10634256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy.
    Thobois S; Broussolle E; Toureille L; Vial C
    Mov Disord; 2001 Jul; 16(4):764-5. PubMed ID: 11481708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial experience with imaging-guided intramuscular botulinum toxin injection in patients with idiopathic cervical dystonia.
    Lee IH; Yoon YC; Sung DH; Kwon JW; Jung JY
    AJR Am J Roentgenol; 2009 Apr; 192(4):996-1001. PubMed ID: 19304706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin A for the treatment of cervical dystonia.
    Zesiewicz TA; Stamey W; Sullivan KL; Hauser RA
    Expert Opin Pharmacother; 2004 Sep; 5(9):2017-24. PubMed ID: 15330738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of the efficacy of botulinum neurotoxin type a in treating cervical dystonia.
    Zhou X; Li ZF; Guo XZ; Wei Q; Niu YN; Li M; Xia JN; Chen LP
    Technol Health Care; 2024; 32(4):2421-2430. PubMed ID: 38073352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posturographic findings in patients with idiopathic cervical dystonia before and after local injections with botulinum toxin.
    Wöber C; Schnider P; Steinhoff N; Trattnig S; Zebenholzer K; Auff E
    Eur Neurol; 1999; 41(4):194-200. PubMed ID: 10343149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A.
    Houser MK; Sheean GL; Lees AJ
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):577-80. PubMed ID: 9598669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia.
    Naumann M; Yakovleff A; Durif F;
    J Neurol; 2002 Jan; 249(1):57-63. PubMed ID: 11954869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of botulinum toxin type A against cervical dystonia and muscular hypertonia in persons with severe motor and intellectual disabilities with respiratory problems and/or dysphagia].
    Yokoyama M; Honda M; Okoshi Y; Masuyama T; Iwasaki Y; Arima M
    No To Hattatsu; 2011 Jul; 43(4):273-6. PubMed ID: 21800689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy analysis of ultrasound-guided local injection of botulinum toxin type A treatment with orthopedic joint brace in patients with cervical dystonia.
    Huang L; Chen HX; Ding XD; Xiao HQ; Wang W; Wang H
    Eur Rev Med Pharmacol Sci; 2015; 19(11):1989-93. PubMed ID: 26125259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia.
    Lu CS; Chen RS; Tsai CH
    J Formos Med Assoc; 1995 Apr; 94(4):189-92. PubMed ID: 7606182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
    Sloop RR; Cole D; Patel MC
    Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
    Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
    Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
    Tan EK; Jankovic J
    Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ptosis as a remote effect of therapeutic botulinum toxin B injection.
    Racette BA; Lopate G; Good L; Sagitto S; Perlmutter JS
    Neurology; 2002 Nov; 59(9):1445-7. PubMed ID: 12427903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.